|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector. |
| 公司地址
| 21925 West Field Parkway, Suite 235, Deer Park, IL, USA, 60010-7278 |
| 電話號碼
| +1 847 787-7361 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.etonpharma.com |
| 員工數量
| 30 |
| Mr. David C. Krempa |
Chief Business Officer |
美元 397.83K |
25/04/2025 |
| Mr. Sean E. Brynjelsen |
President, Chief Executive Officer and Director |
美元 615.54K |
25/04/2025 |
| Mr. James R. Gruber |
Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary |
美元 397.83K |
25/04/2025 |
| Ms. Ipek Erdogan-Trinkaus |
Chief Commercial Officer |
-- |
25/04/2025 |
|
|
| Mr. Paul Victor Maier |
Independent Director |
25/04/2025 |
| Dr. Norbert G. Riedel,PhD |
Chairman of the Board |
25/04/2025 |
| Ms. Jennifer McKie Adams |
Independent Director |
25/04/2025 |
| Mr. Sean E. Brynjelsen |
President, Chief Executive Officer and Director |
25/04/2025 |
| Mr. Charles J. Casamento |
Independent Director |
25/04/2025 |
|
|
|
|
